Haddadin, Olivia M.
Jacobson, Michael E.
Chen, Diana M.
Croitoru, David O.
Dissemond, Joachim
Gontijo, Joao Renato V.
Hampton, Philip J.
Kelly, Robert I.
Marzano, Angelo Valerio
Tada, Yayoi
Gerbens, Louise A. A.
Ortega-Loayza, Alex G.
Article History
Received: 2 August 2023
Revised: 2 August 2023
Accepted: 6 September 2023
First Online: 27 September 2023
Declarations
:
: Dr. Diana Chen is an employee of Genentech, a member of the Roche Group. Dr. David Croitoru worked as a consultant for UCB, Bausche, Novartis, Abbvie and Sanofi. Dr. Angelo Marzano receives consultation and advisory boards disease-relevant honoraria from AbbVie, Boehringer-Ingelheim, Novartis, Pfizer, Sanofi, and UCB. Dr. Yayoi Tada receives research grants and honoraria from Eisai, AbbVie, and Novartis. Dr. Alex Ortega-Loayza is president-elect of Pacific Dermatologic Association, an associate editor of Dermatology (Karger), a consultant for Genentech, Guidepoint, Corvus Pharmaceuticals, and Castle Biosciences, on the advisory board of Bristol Meyer Squibb, Boehringer Ingelheim, and Janssen, and receives research grants from AbbVie, Lilly, Janssen, Pfizer, and InflaRx GmbH. All other authors declare no competing interests.